Moolec Science SA (NASDAQ:MLEC) Short Interest Down 70.1% in March

Moolec Science SA (NASDAQ:MLECGet Free Report) was the recipient of a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 17,317 shares, a decrease of 70.1% from the February 26th total of 57,914 shares. Currently, 3.0% of the shares of the company are short sold. Based on an average daily volume of 103,911 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily volume of 103,911 shares, the days-to-cover ratio is currently 0.2 days. Currently, 3.0% of the shares of the company are short sold.

Moolec Science Trading Down 3.0%

Shares of Moolec Science stock traded down $0.20 on Wednesday, reaching $6.57. 6,772 shares of the stock were exchanged, compared to its average volume of 1,464,811. The firm has a market capitalization of $4.80 million, a PE ratio of -0.20 and a beta of -0.65. Moolec Science has a 1-year low of $3.08 and a 1-year high of $157.05. The business has a fifty day moving average price of $8.78 and a two-hundred day moving average price of $9.33.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Moolec Science to a “sell” rating in a research report on Saturday, February 28th.

Get Our Latest Report on MLEC

Institutional Investors Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC purchased a new stake in Moolec Science SA (NASDAQ:MLECFree Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science at the end of the most recent reporting period. 0.07% of the stock is owned by institutional investors and hedge funds.

Moolec Science Company Profile

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

See Also

Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.